{"name":"Tarsa Therapeutics, Inc.","slug":"tarsa-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Oral Calcitonin Tablets","genericName":"Oral Calcitonin Tablets","slug":"oral-calcitonin-tablets","indication":"Osteoporosis in postmenopausal women","status":"phase_3"}]}],"pipeline":[{"name":"Oral Calcitonin Tablets","genericName":"Oral Calcitonin Tablets","slug":"oral-calcitonin-tablets","phase":"phase_3","mechanism":"Oral calcitonin activates calcitonin receptors on osteoclasts to inhibit bone resorption and reduce bone loss.","indications":["Osteoporosis in postmenopausal women","Bone loss and fracture risk reduction"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPclBWTVp2RTRydkNCNXJyZzRKVkdHLWZyTlRpWG5GWWZXYVNqSWtBRDhhVGtuS1liWlpoZEdIaHpGMDRFZnJzd0o4WTFuQ0lxZmpYTFIyUEJPbHJXMV9wdHlTdFlZOVoxNjFTd3lQQWFaZ3gxSE1nck85M1R2NUVwdF9ldmUtT29PNlJYaDg1UWxocUt0cTZpUkhNVDFfc0ZJbXF3QkpzTVFDcTB2QUxwWEwteTlydmdWTGFaSk1ocm85WFRuc3lLbGoyWmJKQXJHX3R6ZlY5U3FycllaSHc4c2otNmR3bU9FMmhMTnBRNjNRLWlGaC14cXln?oc=5","date":"2026-01-16","type":"pipeline","source":"GlobeNewswire","summary":"Oral Protein and Peptides Market to Hit Valuation of US$ 47.33 Billion By 2035 | Astute Analytica - GlobeNewswire","headline":"Oral Protein and Peptides Market to Hit Valuation of US$ 47.33 Billion By 2035 | Astute Analytica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPNmp3S0Zuc3R4UDg1OGlGb3EyRWQ4QXpQeFBmQWw4N0QyRjNybEF5X0NGX0pyX2dxY0ctN1RTUFkzVFg4SDNKaldUOWZCNkY1RmlpS2NEYXc1V2M3Q1dIZFRKOHJFSzdqNmhIRUFmdFlBVHdMUWtySlYyWkRrdlpKZk9GNlRCNzU3QnRYbUVyWXN0WG5acVZjZ3B5U0l0VHBZUlVWVw?oc=5","date":"2025-11-14","type":"pipeline","source":"industrytoday.co.uk","summary":"Oral Proteins and Peptides Market Know the Scope and Trends - industrytoday.co.uk","headline":"Oral Proteins and Peptides Market Know the Scope and Trends","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE52REZybjNHeUg4WUNWdDU5VzVEc1RRNkFXaTJCUnNvdlBIRE81enk3UE03YnZHVWhlT1VzamVJVnFHTll1MU0xOEVLc1BsUXlhTzRvS3owN1pOSGRidUs4ZkgtNDB4R2l6MVBn?oc=5","date":"2019-06-15","type":"pipeline","source":"Market.us","summary":"Oral Proteins and Peptides Market Size Analysis | CAGR of 10.1% - Market.us","headline":"Oral Proteins and Peptides Market Size Analysis | CAGR of 10.1%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQajlHTzE5LTdKdm5JMldlUUJ2QmcwWTJLbXlHRXdIUEduTDF2U0g4ckxJOUx4Y1FrWU5ucU9McWthOVVubTAzMXBIY2lCQlJpQWtQWUJLMDFrLVR0blZzbkpNcWpTeEFiS1cwd1k3cDhzQTBZRVZUMENIZXBxRFRhaDBqMTU3SncteVBHUFJkQVRteThrSUM1bXFaazAtVXpCWUFDYURR?oc=5","date":"2015-10-19","type":"regulatory","source":"News-Medical","summary":"TARSA Therapeutics' TBRIA NDA accepted by FDA for review - News-Medical","headline":"TARSA Therapeutics' TBRIA NDA accepted by FDA for review - News","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}